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Abstract
The human pathogen Haemophilus influenzae has the ability to quickly adapt to different host environments through phase
variation of multiple structures on its lipooligosaccharide (LPS), including phosphorylcholine (ChoP). During colonization
with H. influenzae, there is a selection for ChoP+ phase variants. In a murine model of nasopharyngeal colonization, this
selection is lost in the absence of adaptive immunity. Based on previous data highlighting the importance of natural
antibody in limiting H. influenzae colonization, the effect of ChoP expression on antibody binding and its bactericidal activity
was investigated. Flow cytometric analysis revealed that ChoP+ phase variants had decreased binding of antibody to LPS
epitopes compared to ChoP2 phase variants. This difference in antibody binding correlated with increased survival of
ChoP+ phase variants in the presence of antibody-dependent, complement-mediated killing. ChoP+ phase variants were
also more resistant to trypsin digestion, suggesting a general effect on the physical properties of the outer membrane.
Moreover, ChoP-mediated protection against antibody binding correlated with increased resilience of outer membrane
integrity. Collectively, these data suggest that ChoP expression provides a selective advantage during colonization through
ChoP-mediated effects on the accessibility of bactericidal antibody to the cell surface.
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Introduction
Haemophilus influenzae is an extracellular, gram-negative patho-
gen that is a primary causative agent of otitis media in children
and is also frequently isolated from adults with pneumonia and
exacerbations of chronic obstructive pulmonary disease (COPD)
[1–5]. Colonization of the upper respiratory tract with H. influenzae
is common and is the first step in disease development, as H.
influenzae carriage is associated with recurrent otitis media episodes
in children [6,7]. While the Hib conjugate vaccine has greatly
reduced the burden of disease caused by type b H. influenzae [8,9],
non-typeable H. influenzae (NTHi) strains, which are unencapsu-
lated, remain a common source of respiratory tract infections.
Vaccine strategies targeting NTHi strains are complicated by the
high variability of outer membrane antigens [10,11]. One of the
structurally diverse molecules on the surface of H. influenzae is the
lipopolysaccharide (LPS).
The LPS of H. influenzae is truncated compared to the LPS of
other gram-negative bacteria. It contains no repetitive O antigen
side chains and is also referred to as lipooligosaccharide (LOS)
[12,13]. H. influenzae LPS consists of lipid A attached to 3-deoxy-
D-manno-oct-2-ulosonic acid (KDO), with three conserved inner
core heptoses to which various oligosaccharide extensions, and
other non-carbohydrate molecules, can be attached [14]. Mass
spectrometry (MS) analysis of different H. influenzae isolates has
revealed a significant level of diversity in LPS structures [15–21].
For example, the length and composition of the hexose extensions
from the inner core heptoses, as well as the attachment of
molecules such as sialic acid and glycine, varies both between
different strains and within glycoforms of the same isolate. A major
source of LPS variability in H. influenzae is on-off switching, or
phase variation, involving LPS biosynthesis genes [22,23]. One of
the phase variable molecules expressed on H. influenzae LPS is
phosphorylcholine.
Phosphorylcholine [(CH3)3N
+CH2CH2PO4
2], or ChoP, is a
small, zwitterionic molecule that is covalently attached to the LPS
through its phosphate group. ChoP is a surface structure of a
number of bacteria in addition to H. influenzae, particularly those
found in the respiratory tract, including Streptococcus pneumoniae,
Pseudomonas aeruginosa, and Neisseria species [24–26]. ChoP is also a
component of eukaryotic membrane lipids in the form of
phosphatidylcholine. H. influenzae must acquire choline from the
environment, and turnover of host lipids can be a major source of
choline during colonization [27,28]. Choline import, phosphor-
ylation, and attachment to H. influenzae LPS is controlled by genes
in the lic1 locus. The choline kinase gene lic1A contains a
tetranucleotide repeat that is responsible for ChoP phase
variation. Slipped-strand mispairing within the repeat region of
lic1A creates a translational on-off switch controlling ChoP
expression [29]. As a result, the control of ChoP attachment to
the LPS is stochastic, and phase variation occurs at a high
frequency [30].
Phase variation of ChoP expression may provide a mechanism
for Haemophilus to display a variety of phenotypes, allowing rapid
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LPS enables recognition by C-reactive protein (CRP), which binds
to ChoP and initiates classical pathway complement-mediated
killing [31]. In host environments with high levels of CRP, such as
in the blood, there is a selective advantage for ChoP2 phase
variants [32]. In addition, an antibody response can be initiated
against LPS epitopes containing ChoP [33,34]. However, the
maintenance of phase variable ChoP expression predicts that there
are also advantages for ChoP+ bacteria in select host environ-
ments. During H. influenzae colonization there is a strong selection
for ChoP+ phase variants. This selection has been observed in
several animal models of Haemophilus colonization, as well as
during human carriage [31,35–37]. ChoP expression increases
adherence to epithelial cells through interaction with platelet-
activating factor receptor (rPAF), which normally binds the ChoP-
containing molecule PAF. While in vitro experiments have
demonstrated the capacity of ChoP+ bacteria to bind rPAF, mice
deficient in rPAF have no colonization defect [38,39]. These data
suggest that there are additional host factors involved in the
selection for ChoP+ bacteria during colonization. Here, we show
that ChoP attachment to the LPS alters the physical properties of
the outer membrane and reduces antibody binding to the surface
of H. influenzae.
Results
Adaptive immunity is required for the selection of ChoP+
phase variants during colonization
The role of adaptive immunity in the selection of ChoP+ phase
variants was examined in vivo using a murine model of
nasopharyngeal colonization. The percentage of ChoP+ phase
variants was determined by colony immunoblotting following
colonization with a mixture of ChoP+/2 variants of strain H632,
an NTHi strain that is able to colonize mice [40]. The proportion
of ChoP+ phase variants in the output (colonizing) population was
substantially greater than that in the input (inoculum) after
challenge of immune competent, (wild-type) BALB/c mice
(Figure 1). In contrast, there was no evidence for a selection of
ChoP+ phase variants following colonization in BALB/c mice
lacking an adaptive immune system (severe combined immune
deficiency, or SCID) [41]. These results demonstrate that adaptive
immunity is important for the selection of ChoP+ phase variants
during colonization.
ChoP expression reduces antibody binding to the surface
of H. influenzae
The importance of natural, or pre-existing, antibody in limiting
H. influenzae colonization has been demonstrated previously [40].
These data led to an examination of the impact of ChoP
expression on antibody binding by flow cytometry. It was found
that ChoP+ variants had reduced antibody binding to their
surface compared to ChoP2 variants (Figure 2). The ChoP+
phase variant of NTHi strain H233 had decreased binding of
natural IgG using both serum from (wild-type) BALB/c mice
(Figure 2A) and normal human serum (NHS; Figure 2C).
Revertants of the originally selected phase variants of strain
H233, as well as ChoP+/2 phase variants in another NTHi
strain, H729, showed a similar effect (Figure 2A, C). The ChoP-
mediated reduction of the binding of natural antibody in serum
(naı ¨ve control) was also observed in the serum of mice previously
intranasally immunized with H. influenzae (Figure 2B). To confirm
the difference in antibody binding was not dependent on other
serum components, the effect of ChoP on binding of IgG purified
from NHS was also examined, with the same result (Figure 2D).
This binding assay was also conducted using a mutant strain of
Rd with constitutive ChoP+ expression (phase locked ChoP+),
H491. This strain was grown in chemically defined medium
(CDM) with or without choline. The binding of IgG in NHS to
H491 was reduced when choline was added to the CDM,
compared to CDM without choline (Figure 2E). ChoP expression
also reduced binding of IgA from NHS (Figure 2F), from human
nasal secretions (Figure 2G), and IgM purified from NHS
(Figure 2H).
To examine whether there was an additional effect of ChoP
expression on binding of complement component C3, baby rabbit
serum (BRS) was used as a source of complement without natural
antibody to H. influenzae. While there was no difference C3 binding
to ChoP+/2 phase variants in BRS alone, the ChoP+ phase
variant of strain H233 had reduced C3 binding in the presence of
BRS with purified IgG from NHS (Figure 2I). Collectively, these
data demonstrate that ChoP expression results in decreased
antibody binding, which limits complement deposition, on the
surface of H. influenzae.
Figure 1. Adaptive immunity is required for selection of ChoP+
phase variants during colonization. BALB/c or BALB/c (severe
combined immune deficiency, or SCID) mice were intranasally
inoculated with 10
7 CFU/mL of a 3:1 mixture of ChoP2:ChoP+ phase
variants of NTHi strain H632. The percentage of ChoP+ phase variants
was determined by colony immunoblotting of the inoculum (input,
white bars) and the nasal lavage fluid following three days of
colonization (output, stippled bars). Values are derived from five mice
per group 6 SD, ***p,.0001.
doi:10.1371/journal.ppat.1002521.g001
Author Summary
The bacterial pathogen Haemophilus influenzae evades
immune responses during colonization in its human host.
Decoration of the bacterial surface with different struc-
tures is one way that Haemophilus avoids host recognition.
In this study, we show that the attachment of the small
molecule phosphorylcholine, or ChoP, to the lipopolysac-
charide covering the bacterial surface allows H. influenzae
to avoid the immune response by inhibiting antibody
binding. The presence of ChoP alters the bacterial surface
to reduce its accessibility. The ability of ChoP to affect
antibody binding is dependent on the positive charge of
the molecule, which changes the physical properties of the
bacterial membrane. The increased survival of bacteria
with ChoP attached to their surface enriches ChoP+
bacteria during colonization. This study reveals a novel
mechanism for bacterial evasion of a host immune
response.
Phosphorylcholine Allows Evasion of Antibody
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bactericidal antibody
The classical pathway of complement-mediated killing can be
initiated by binding of CRP or bactericidal antibody to H.
influenzae. In order to determine if ChoP expression affects classical
pathway complement-mediated killing following antibody binding,
NHS depleted of C-reactive protein (CRP) was used as an
antibody and complement source for bactericidal assays. ChoP+
phase variants had increased survival in CRP-depleted NHS
compared to ChoP2 variants of strain H233, as well as revertants
of the originally selected phase variants (Figure 3A). There was
also increased survival of the ChoP+ phase variant of H233 using
IgG purified from NHS (in the same concentration as that used for
flow cytometry in Figure 2D) with BRS as a complement source
(Figure 3B). The increased survival of ChoP+ bacteria in the
presence of CRP-depleted NHS was observed for multiple other
NTHi strains, constitutive ChoP+ and ChoP2 mutants in Rd, and
an H. influenzae type b strain (Eagan) (Figure 3C). Serum was IgG-
depleted to determine whether the difference in survival of ChoP
variants was dependent on antibody. In IgG-depleted NHS there
was a recovery of survival for the ChoP2 variant of H233, while
the addition of purified IgG restored killing (Figure 3D). No
differences in survival were detected for bactericidal assays
conducted in BRS as a source of complement without antibody,
or in NHS with MgEGTA buffer, which allows alternative
pathway complement-mediated killing only (not shown). Collec-
tively, these results suggest that ChoP expression increases survival
in the presence of bactericidal antibody.
The potential targets on the surface of H. influenzae that are
protected from antibody binding by ChoP expression were
examined using antibody-depleted NHS and mAbs. Purified
LPS was used to absorb LPS–specific antibodies from NHS prior
Figure 2. ChoP expression decreases antibody binding to the bacterial surface. Flow cytometric analysis was used to quantify antibody
binding to bacterial cells. Representative histogram of BALB/c serum IgG binding to phase variants of NTHi strain H233, and the mean fluorescence
intensity (MFI) for binding to H233 phase variants and revertants of the originally selected phase variants (A). MFI of IgG binding from the serum of
naı ¨ve (intranasally inoculated with PBS) or immune (intranasally inoculated with constitutive ChoP2 type b strain H445) BALB/c mice to phase
variants of type b (unencapsulated) strain H625 (B). The MFI of normal human serum (NHS) IgG binding to phase variants of NTHi strains H233 and
H729 (C) and purified IgG for strain H233 (D). The MFI of NHS IgG binding for Rd constitutive ChoP+ strain H491 grown in CDM alone (grey bar) or
supplemented with choline ((CH3)3N
+CH2CH2, black bar) or dimethylethanolamine ((CH3)2NCH2CH2, stippled bar), (E). The MFI of IgA binding for
phase variants of H233 using NHS (F) or pooled human nasal secretion IgA binding (G). The MFI of IgM purified from NHS binding for phase variants
of H233 and Rd (H). The MFI of C3 binding from BRS to phase variants of H233 in the presence or absence of purified IgG (from NHS) (I). ChoP+
variants are shown in black bars, ChoP2 variants are shown in grey bars. Values are derived from at least three independent experiments 6 SD,
*p,.05, **p,.01, ***p,.001.
doi:10.1371/journal.ppat.1002521.g002
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with wt, constitutive ChoP2 LPS resulted in increased survival of
the constitutive ChoP2 mutant in Rd, H446 (Figure 4B). In
contrast, there was no increase in survival of the constitutive
ChoP2 mutant after pre-absorption with ChoP2 LPS from the
Rd opsX mutant strain, which is highly truncated with no KDO
heptose extensions (Figure 4A, B). To confirm that the LPS pre-
absorbed serum retained complement activity, purified IgG was
added back to the LPS pre-absorbed serum, and killing was
observed (not shown). These results indicate that the majority of
the bactericidal antibody affected by ChoP expression in NHS is
LPS oligosaccharide-specific. Of note, that there was a greater
increase in the survival of the Rd constitutive ChoP2 mutant
H446 following NHS pre-absorption with ChoP2 LPS, compared
to pre-absorption with ChoP+ LPS, a result that correlated with
the effect of ChoP on antibody binding (Figure 4B). While purified
LPS may not accurately mimic the environment of the outer
membrane, this result demonstrates that the same decrease in
antibody binding observed in ChoP+ whole bacteria is also
observed for ChoP+ LPS.
The mAb 6E4, which binds H. influenzae LPS [42], was used to
examine the effect of ChoP on antibody binding to a specific LPS
epitope. ChoP expression reduced 6E4 binding and increased
survival following incubation in 6E4 with BRS as a complement
source (Figure 4C, D). This was observed for NTHi strain H729
and for the constitutive ChoP+ mutant in Rd, H491. These results
confirmed that ChoP expression provides protection against
bactericidal antibody binding to LPS oligosaccharide epitopes.
LPS structural requirements for the effect of ChoP on
antibody binding
A selection of LPS mutants in Rd was used to investigate the
importance of the LPS molecular environment for ChoP-mediated
protection against antibody binding (Figure 4A). The ChoP+
phase variant of the lpsA mutant strain, which no longer has HepIII
hexose extensions, maintained reduced antibody binding and
Figure 3. ChoP expression protects against bactericidal antibody. Percent survival in C-reactive protein (CRP)-depleted NHS (relative to
complement-inactivated control) is shown for phase variants of NTHi strain H233 and revertants of the originally selected phase variants (A). Percent
survival in purified IgG from NHS with BRS (complement source) for phase variants of H233 (B). Percent survival in CRP-depleted NHS for constitutive
ChoP+ and ChoP2 mutants in Rd, phase variants of type b strain Eagan, and multiple NTHi strains (C). Percent survival of NTHi strain H233 ChoP2
phase variant in NHS, IgG-depleted NHS, or in IgG-depleted NHS supplemented with purified IgG, is shown as indicated (D). ChoP+ variants are
shown in black bars, ChoP2 variants are shown in grey bars. Values are derived from at least three independent experiments 6 SD, *p,.05, **p,.01,
***p,.001.
doi:10.1371/journal.ppat.1002521.g003
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(Figure 5). In contrast, there was no longer a protective effect of
ChoP expression on antibody binding and complement-mediated
killing for the orfH and lpt6 mutant strains. The orfH mutation
results in a lack of HepIII, while the lpt6 mutation prevents
attachment of a conserved phosphoethanolamine molecule to
HepII.
ChoP can be attached to hexose extensions from multiple
heptose residues, most commonly HepI and HepIII [20,43,44].
The importance of the position of ChoP for its effect on antibody
binding was examined using lic1D exchange mutants, as the lic1D
allele dictates the position of ChoP attachment [45]. In Rd, ChoP
is attached to a hexose extension on HepI (HI). Alteration of the
position of ChoP in Rd from H1 to a hexose extension on HepIII
(H3) resulted in the loss of ChoP-mediated protection against
antibody binding and antibody-dependent bactericidal activity
(Figure 6). Collectively, these data demonstrate that the constit-
uents of the oligosaccharide and the molecular environment of
ChoP are both important for the effect of ChoP on antibody
binding and resistance to antibody-dependent, complement-
mediated killing.
ChoP expression alters the physical properties of the
outer membrane
We next investigated the mechanism for ChoP-mediated
protection against antibody binding, considering two possibilities;
1) steric hindrance, where ChoP obscures key epitope(s) and 2)
ChoP alteration of the physical properties of the outer membrane,
resulting in decreased membrane accessibility. In order to test the
effect of ChoP expression on the ability of molecules other than
antibodies to access the membrane, trypsin sensitivity was
compared for ChoP+ and ChoP2 phase variants. The fluorescent
dye Cy5, which labels lysine residues, was used to quantify the
exposure of outer membrane surface proteins by flow cytometry.
Following trypsin digestion, there was decreased Cy5 binding to
the ChoP2 phase variant of strain H233, as well as the ChoP2
revertant of the original ChoP+ phase variant (Figure 7A). The
same effect was observed for the constitutive ChoP2 mutant in
Figure 4. ChoP expression reduces binding of LPS bactericidal antibody. Rd LPS structure with arrows indicating sites of truncations for LPS
biosynthesis mutants (A). Percent survival (relative to complement-inactivated control) for Rd constitutive ChoP2 strain H446 in NHS that was
absorbed with: purified Rd LPS from the constitutive ChoP+ mutant, the constitutive ChoP2 mutant, or an opsX mutant (B). Flow cytometric analysis
of the MFI of mAb 6E4 binding to phase variants of NTHi strain H729 and constitutive ChoP+ and ChoP2 mutants in Rd (C). Percent survival in BRS
(complement source) and mAb 6E4 for phase variants of NTHi strain H729 and constitutive ChoP+ and ChoP2 mutants in Rd (D). ChoP+ variants are
shown in black bars, ChoP2 variants are shown in grey bars. Values are derived from at least three independent experiments 6 SD, *p,.05, **p,.01,
***p,.001.
doi:10.1371/journal.ppat.1002521.g004
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trypsin digestion suggests that ChoP expression affects the general
accessibility of molecules, including antibodies, to outer membrane
targets.
In order to further examine the effect of ChoP on the physical
properties of the outer membrane, membrane barrier function was
compared in ChoP+ and ChoP2 phase variants. Bacterial uptake
of the dye ethidium bromide (EtBr) was used to measure the effect
of ChoP on the permeability of the outer membrane. The rate-
limiting step for EtBr uptake is transversal of the outer membrane
[46]. In the presence of a low concentration of polymyxin B, there
was an increased rate of EtBr uptake in the ChoP2, compared to
the ChoP+, phase variants of H233 (Figure 7B). The same effect
was observed for the revertants of the original variants of strain
H233 as well as the constitutive ChoP+ and ChoP2 mutants in
Rd (Figure 7B). It was necessary to include polymyxin B to cause
initial membrane destabilization for dye uptake. While ChoP
expression does not affect killing by polymyxin B alone (not
shown), the difference in EtBr uptake rates may reflect a difference
in outer membrane susceptibility to polymyxin B. The alteration of
polymyxin B-induced EtBr uptake demonstrates that ChoP
expression strengthens the barrier function of the outer mem-
brane.
Differences in membrane barrier function often correlate with
changes in the gel-to-liquid crystalline phase transition temper-
ature, or Tm, which can be determined by differential scanning
calorimetry (DSC) [47]. In order to test the effect of ChoP
expression on the Tm of H. influenzae LPS, DSC was performed
on LPS purified from ChoP+ and ChoP2 bacteria. The Tm of
LPS from the Rd constitutive ChoP+ strain H491 was
determined to be 29.86.2uC, while the Tm of the constitutive
ChoP2 mutant strain H446 was significantly higher, at
34.36.1uC( p ,.0001). Phase transition temperatures were
independent of Mg
2+ concentration.
The effect of ChoP on the integrity of the outer membrane
was examined by comparing EDTA sensitivity in ChoP+ and
ChoP2 phase variants. EDTA treatment chelates the divalent
cations that are important for maintaining LPS interactions and
membrane stability [48]. The ChoP+ variant of strain H233 had
increased resistance to EDTA, compared to the ChoP2 variant
Figure 5. Core LPS structures are required for ChoP-mediated protection against antibody binding. Flow cytometric analysis of the MFI
of IgG binding to phase variants of Rd LPS mutant strains lpsA, orfH, and lpt6 following incubation in BALB/c serum (A) or NHS (B). Percent survival in
CRP-depleted NHS (relative to complement-inactivated control) for phase variants of Rd mutant strains (C). ChoP+ variants are shown in black bars,
ChoP2 variants are shown in grey bars. Values are derived from at least three independent experiments 6 SD, *p,.05, **p,.01.
doi:10.1371/journal.ppat.1002521.g005
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trend (not shown). Growth of the Rd constitutive ChoP+ strain
H491 in CDM with choline also resulted in increased EDTA
resistance, compared to survival following growth in CDM
without choline (Figure 8B). In contrast, the expression of a
digalactoside residue (Gala1-4Gal) in strain H233, detected
by the mAb 4C4, had no impact on EDTA resistance
(Figure 8A).
The importance of the position of ChoP for its effect on outer
membrane integrity was also investigated. For the Rd lic1D
exchange mutant strains, only ChoP in the H1, but not H3,
position resulted in increased EDTA resistance (Figure 8C, D).
These results correlate with the effect of ChoP position on
antibody binding, suggesting that the same structural requirements
for ChoP-mediated reduction of antibody binding are necessary
for its effect on the integrity of the outer membrane. Next, the
effect of divalent cation concentration on antibody binding was
explored. Increasing the Mg
2+ concentration (up to 50 mM)
resulted in reduced antibody binding to the ChoP2 phase variant
of H233 (Figure 8E). These results demonstrate that excess Mg
2+,
which increases the stability of the outer membrane [49–51], can
correct for the difference in antibody binding between ChoP+ and
ChoP2 variants. Together, these data indicate that ChoP
expression alters the physical properties of the outer membrane,
and that these effects correlate with the reduction of antibody
binding in ChoP+ phase variants.
ChoP structural requirements for its effect on antibody
binding and outer membrane integrity
ChoP is a zwitterionic molecule with a positively charged
quaternary amine group, which may be important for its effect on
antibodybindingandthephysicalpropertiesoftheoutermembrane.
The structural components of ChoP thatare requiredfor its effecton
antibody binding and the integrity of the outer membrane were
examined using a strain that incorporated a ChoP analog,
dimethylethanolamine phosphate [(CH3)2NCH2CH2PO4
2]. This
ChoP analog differs from ChoP by a single methyl group, which
reduces the positive charge on the amine group with minimal
Figure 6. Position of ChoP affects ChoP-mediated protection against antibody binding. Flow cytometric analysis of the MFI of IgG
binding to phase variants of Rd lic1D exchange mutants; H491 with Rd lic1D (HeptoseI, or H1), and H457 with Eagan lic1D (HeptoseIII, or H3), from
BALB/c serum (A) or NHS (B). Percent survival (relative to complement-inactivated control) was determined following incubation in CRP-depleted NHS
(C). ChoP+ variants are shown in black bars, ChoP2 variants are shown in grey bars. Values are derived from at least three independent experiments
6 SD, *p,.05, **p,.01.
doi:10.1371/journal.ppat.1002521.g006
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into the LPS of the Rd constitutive ChoP+ strain H491 grown in
CDM+dimethylethanolamine was confirmed by MS (not shown).
H491 grown in CDM+dimethylethanolamine had a similar level of
antibody binding as when the strain was grown in CDM alone
(Figure 2E). In addition, while H491 grown in CDM+choline had
increasedEDTAresistancecomparedtowhenitwasgrowninCDM
alone, H491 grown in CDM+dimethylethanolamine showed the
samepercent survivalinEDTA as whenitwasgrown inCDM alone
(Figure8B).While it cannotbe ruled outthat thesingle methylgroup
impacts thestericinhibition of antibodybinding,theseresultssuggest
that the positively charged quaternary amine on ChoP is important
for the reduced antibody binding and increased outer membrane
integrity observed in ChoP+ phase variants.
Discussion
Understanding the requirements for H. influenzae colonization is
integral to the effort to reduce the burden of NTHi-associated
disease. H. influenzae is susceptible to antibody-dependent, classical
pathway complement-mediated killing in vitro, and this may be an
important mechanism for host control of H. influenzae in vivo. For
example, human patients with primary antibody deficiencies have
persistent colonization and higher rates of disease from NTHi
strains [52]. In this light, bacterial factors that affect antibody
recognition could play a major role in H. influenzae survival during
colonization. In this study, it was found that ChoP+ phase variants
have reduced binding of antibody, including antibody binding to
LPS epitopes, as well as increased survival in the presence of
Figure 7. ChoP expression affects outer membrane accessibility and barrier function. Flow cytometric analysis of the MFI of Cy5 binding
to outer membrane surface proteins following trypsin digestion for phase variants of NTHi strain H233 and revertants of the originally selected phase
variants and constitutive ChoP+ and ChoP2 mutants in Rd (A). Rate of ethidium bromide (EtBr) uptake, expressed in relative fluorescent units per
second (RFU/s), in the presence of polymyxin B for phase variants of NTHi strain H233 and revertants and constitutive ChoP+ and ChoP2 mutants in
Rd (B). ChoP+ variants are shown in black bars, ChoP2 variants are shown in grey bars. Values are derived from at least three independent
experiments 6 SD, *p,.05, **p,.01, ***p,.001.
doi:10.1371/journal.ppat.1002521.g007
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was no difference in C3 deposition or bacterial survival for
ChoP+/2 phase variants in the absence of antibody, the
experiments conducted in the present study do no exclude the
possibility that ChoP expression affects binding of other classical
pathway complement components. The major bactericidal
antibody from the serum sources in this study was IgG, which
can reach the site of colonization through transcytosis [53,54].
Indeed, nasal lavage fluid from BALB/c mice contains IgG that
binds H. influenzae targets, including LPS, and a role for
complement in limiting H. influenzae colonization has also been
demonstrated [40]. Increased resistance to bactericidal antibody
was observed for ChoP+ phase variants of multiple H. influenzae
strains, despite the heterogeneity observed in this bacteria [55].
These data demonstrate a novel mechanism for evasion of
antibody recognition by H. influenzae during colonization. It was
also shown that adaptive immunity is required for the increase in
the selection of ChoP+ phase variants during colonization. While
the short-term colonization model used for the in vivo experiments
demonstrates a role for ChoP expression in protection against
natural antibodies, it was also shown that ChoP+ phase variants
have reduced binding of antibody from pre-exposed, immune
hosts. Taken together, these results suggest that ChoP expression
provides a selective advantage at the mucosal surface during
colonization, as ChoP+ bacteria are better protected against
antibody binding and antibody-dependent clearance.
ChoP is one of several LPS structural determinants whose
attachment to the LPS is controlled by stochastic phase variation
[29,56]. Other phase variable decorations to the LPS have been
shown to have an effect on serum resistance. For example, loss of
O-acetylation, sialylation, or the digalactoside residue Gala1,4Gal
results in increased serum sensitivity, attributed to different
mechanisms [57–59]. The LPS of H. influenzae is highly
heterogeneous [60], and phase variation of LPS epitopes may
allow bacteria to quickly adapt to the repertoire of antibodies
present in different host environments. While it was shown in the
current study that ChoP+ phase variants have reduced binding of
the mAb 6E4, the full scope of the LPS, or non-LPS, epitopes
protected from antibody recognition by ChoP expression remains
unknown. As mentioned previously, ChoP attachment to surface
structures has been observed in several bacterial species. In
addition to the LPS, ChoP has been found in bacteria on teichoic
acid, pili, and an elongation factor protein [61–63]. It has also
recently been shown that an effector protein injected by Legionella
pneumophila modifies host regulatory factors with ChoP [64]. The
current study supplies another example of how the attachment of
this ubiquitous molecule modulates the properties of its target.
The importance of the molecular environment of the LPS for
ChoP-mediated protection against antibody binding was exam-
ined using a set of LPS mutants. It was found that two conserved
inner core LPS structures (PEtn and HepIII) are required for the
reduction of antibody binding in ChoP+ phase variants. This
result could be due to the direct loss of epitopes that are normally
protected against antibody binding by ChoP expression, or
through an indirect effect of these structures on binding of
antibody to other LPS epitopes. Previously, it was shown that
changing the location of ChoP attachment affects sensitivity to
CRP [45]. In accordance with this data, we determined that the
position of ChoP attachment to the LPS is important for the effect
of ChoP on antibody binding in Rd. While the inner core structure
of LPS is conserved among H. influenzae strains, ChoP can be
attached to hexose extensions off of any of the three inner core
heptoses or to a fourth heptose present in some NTHi strains
[17,18,20]. There are also NTHi strains with a partial duplication
of the lic locus, resulting in the attachment of two ChoP residues to
the LPS in ChoP+ phase variants [65]. Each H. influenzae strain
Figure 8. ChoP expression increases outer membrane integrity. Percent survival following incubation in EDTA was determined for ChoP+
(black solid), ChoP2 (grey solid), and ChoP2,Gala1-4Gal+ (grey dashed) phase variants of NTHi strain H233 (A). Percent survival in EDTA for Rd
constitutive ChoP+ strain H491 grown in CDM alone (grey solid), or supplemented with choline (black solid) or with dimethylethanolamine (grey
dashed) (B). Percent survival in EDTA for Rd lic1D exchange mutants, Rd lic1D (H1) (C) and Eagan lic1D (H3) (D). Flow cytometric analysis of the MFI of
NHS IgG binding in the presence of 0–50 mM Mg
2+ for ChoP+ (black bars) and ChoP2 (grey bars) phase variants of NTHi strain H233 (E). Values are
representative of three independent experiments performed in duplicate 6 SD (A–D), or are derived from three independent experiments 6 SD
*p,.05, **p,.01 (E).
doi:10.1371/journal.ppat.1002521.g008
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ChoP-mediated protection against antibody binding. The variable
position of ChoP also argues against its main function being
sterically hindering antibody binding to other LPS epitopes.
The finding that ChoP+ phase variants of H. influenzae are also
less sensitive to trypsin digestion of outer membrane proteins led to
the investigation of the effect of ChoP on the physical properties of
the outer membrane. The reduced access of a non-antibody
molecule to the membrane suggests that the effect of ChoP on
antibody binding is due to a general effect on the outer membrane,
rather than direct steric hindrance. This concept is supported by a
recent study from this lab demonstrating that mutations in H.
influenzae that change the distribution of phospholipids in the outer
membrane result in decreased outer membrane stability and
increased antibody binding to LPS epitopes [66].
In support of the hypothesis that ChoP expression affects the
physical properties of the outer membrane, it was shown that
ChoP+ phase variants have reduced sensitization to treatments
that may compromise the outer membrane, such as polymyxin B-
induced EtBr permeability. Polymyxin B is a cationic peptide that
targets negatively charged residues in the LPS [67]. A previous
study demonstrated that ChoP expression reduces sensitivity to
killing by the cationic antimicrobial peptide LL-37 [68], further
supporting a ChoP-mediated impact on the integrity of the outer
membrane. While studies in several bacterial species have shown
that lipid A modifications can affect antimicrobial resistance and
membrane permeability [46,49,69,70], the data presented in the
current paper demonstrate that modifications outside of the lipid
A-KDO inner core region can also impact membrane integrity
and barrier function. DSC has been used to determine the phase
transition temperatures of phospholipid membrane systems as well
as purified LPS from various bacterial strains [71,72]. In the
current study, the phase transition temperature for purified LPS
from a constitutive ChoP+ strain was found to be reduced
compared to that for ChoP2 LPS. A similar trend is observed in
phospholipid membrane systems, where the addition of lipids
containing ChoP reduce membrane permeability and the Tm [47].
In DSC experiments using LPS isolated from Salmonella minnesota,i t
was found that mutants with reduced oligosaccharide extensions
had a lower Tm, demonstrating that changes to the oligosaccha-
ride, in addition to lipid A alterations, can affect the phase
transition temperature [51,73].
It was shown in the current study that ChoP+ phase variants of
H. influenzae have increased resistance to membrane disruption by
EDTA. EDTA chelates the divalent cations that are important for
the stabilization of the outer membrane through association with
multiple negatively charged phosphate groups on the LPS [50,74].
It has been shown that EDTA treatment causes loss of outer
membrane organization and shedding of LPS molecules, resulting
in reduced membrane integrity [74,75]. The modification of outer
membrane integrity correlated with an effect on antibody binding,
as the addition of Mg
2+ alone resulted in decreased antibody
binding. While ChoP is a relatively small structural addition to H.
influenzae LPS, the presence of the positively charged quaternary
amine group may impact the outer membrane by altering charge
interactions. It was shown in this study that bacteria that
incorporated dimethylethanolamine phosphate instead of ChoP
did not have reduced antibody binding or increased EDTA
resistance. These data indicate that the positively charged amine
group, rather than the negatively charged phosphate group, is
required for the effect of ChoP on outer membrane integrity and
antibody binding. The expression of molecules with amine groups
on lipid A, as well as KDO, has been shown to increase outer
membrane stability in other bacteria [76,77]. Our study suggests a
similar effect through modification of the outer core of the
oligosaccharide with ChoP. This also supports the notion that a
large part of the effect of ChoP on antibody binding is indirect,
through alteration of outer membrane accessibility, rather than
direct steric inhibition.
In summary, these data indicate that ChoP expression increases
the barrier function and integrity of the outer membrane, and
these alterations correlate with a reduction in the accessibility and
binding of antibody to ChoP+ phase variants. Phase variation of
ChoP may be an important consideration in the design of NTHi
vaccines targeting LPS epitopes, as selection for ChoP+ phase
variants could abrogate vaccine effectiveness. In contrast, vaccines
targeting ChoP would select for ChoP2 phase variants, and
thereby increase effective immune responses to other cell surface
epitopes. While phase variation of LPS structures can directly alter
the presence of specific epitope(s), these data suggest a novel
mechanism whereby ChoP expression affects the ability of
antibody to recognize bacterial targets by altering access to outer
membrane antigens.
Materials and Methods
Ethics statement
This study was conducted according to the guidelines outlined
by National Science Foundation Animal Welfare Requirements
and the Public Health Service Policy on the Humane Care and
Use of Laboratory Animals. The protocol was approved by the
Institutional Animal Care and Use Committee, University of
Pennsylvania Animal Welfare Assurance Number A3079-01.
Bacterial strains
All strains are listed in Table 1. Strains were grown in brain
heart infusion media (Becton Dickinson Biosciences, Franklin
Lake, NJ) supplemented with Fildes enrichment (Remel, Lenexa,
KS) and 20 mg/mL b-Nicotinamide adenine dinucleotide hydrate
(Sigma, St. Louis, MO), referred to as sBHI. When specified,
strains were grown in CDM, prepared as previously described
[78]. CDM was supplemented with 300 mM of choline chloride or
the choline analog N,N-Dimethylethanolamine (Sigma) where
indicated. Selection of ChoP and Gala1-4Gal containing phase
variants was performed by colony immunoblotting as previously
described [79]. Revertants of ChoP variants were selected in the
same manner. Each ChoP phase variant population was
determined to be over 98% ChoP+ or ChoP2 by colony
immunoblotting, and constitutive ChoP mutants were 100%
ChoP+ (H491) or ChoP2 (H446). The percentage of ChoP+ and
ChoP2 bacteria in each phase variant population remained
constant during growth to log phase, as there is no selective
pressure on ChoP expression in vitro. ChoP+ colonies transferred to
a nitrocellulose membrane were detected using a 1:10,000 dilution
of the monoclonal antibody TEPC-15 (Sigma) followed by a
1:10,000 dilution of alkaline phosphatase-conjugated anti-mouse
IgA (Sigma). Colonies expressing the Gala1-4Gal structure were
selected using a 1:10,000 dilution of the monoclonal antibody 4C4
[80] followed by a 1:10,000 dilution of alkaline phosphatase-
conjugated anti-mouse IgG (Sigma).
Mouse nasopharyngeal colonization
Colonization studies were conducted as described previously
[40]. Briefly, mice were intranasally inoculated with 10
7 CFU/mL
of bacteria that were first washed and diluted in phosphate-
buffered saline (PBS). ChoP variants were grown separately,
followed by combination at a 3:1 ratio of ChoP2 : ChoP+ bacteria
by volume prior to inoculation. Nasal lavage fluid was collected in
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streptomycin following three days of colonization. Bacterial counts
obtained by nasal lavage were comparable to those collected by
plating nasopharyngeal tissue homogenates. The percentage of
ChoP+ colonies was determined through detection of ChoP by
colony immunoblotting.
Flow cytometric analysis
Antibody binding was detected by flow cytometry as previously
described [66]. Briefly, 200 ml reactions containing mid-logarith-
mic phase bacterial cells in Hank’s buffer without Ca2+ or Mg2+
(Gibco, San Diego, CA) supplemented with 5% fetal calf serum
(HyClone, Logan, UT) were incubated with primary antibody for
60 min at 37uC. Primary antibody sources included naı ¨ve BALB/
c serum (1:200 dilution), NHS (1:200 dilution), IgG purified from
NHS (Sigma, 4.8 mg), IgM purified from NHS (Sigma, 3.7 mg),
normal human nasal secretions (1:200 dilution), mAb 6E4 (1:100
dilution for H729, 1:500 dilution for Rd), and BRS (1:50 dilution).
Serum collected from BALB/c mice that had been intranasally
inoculated at day 0, 7, and 14 with either PBS (naı ¨ve) or
10
7 CFU/mL of constitutive ChoP2 type b strain H445 (immune)
was also used as a source of primary antibody (1:20 dilution).
Reactions mixtures were then washed and re-suspended in 1:200
dilutions of secondary antibody, followed by incubation at 4uC for
60 min. Secondary antibodies included goat anti-mouse IgG-
FITC, goat anti-human IgG-FITC, goat anti-human IgA-FITC,
goat anti-human IgM-FITC (Sigma), and goat anti-rabbit
polyclonal C3-FITC (MP Biomedical Chappel, Irvine, CA).
Reaction mixtures were then washed and re-suspended in PBS
with 1% bovine serum albumin and 0.5% paraformaldehyde prior
to flow cytometric analysis on a BD FACS Calibur flow cytometer
(Becton Dickinson Biosciences). A total of 50,000 cells were
collected from each reaction mixture, and the MFI of antibody
binding was determined using FlowJo software (Tree Star,
Ashland, OR).
Bactericidal assays
Assays were conducted in 200 ml reaction mixtures containing
20 ml of mid-logarithmic phase bacterial cells (OD620 0.5) diluted
to 10
5 CFU/mL in Hank’s buffer with Ca
2+ and Mg
2+ (Gibco).
Following the addition of serum, reaction mixtures were incubated
for 45 min at 37uC. One serum source was CRP-depleted NHS,
used at a 1:10 dilution for H233 and Eagan, a 1:5–1:10 dilution
for other NTHi strains, and a 1:50 dilution for Rd. CRP was
depleted from NHS using immobilized p-aminophenyl phosphoryl
choline gel, which also results in depletion of anti-ChoP
antibodies, according to the manufacturer’s protocol (Thermo
Scientific, Rockford, IL). Another serum source was a 1:20
dilution of BRS, to which purified IgG from NHS was added
(Sigma, 4.8 mg). IgG depletion of NHS was performed using a
Protein G column (GE Healthcare Bio-Sciences, Uppsala,
Sweden). IgG eluted from the Protein G column according to
manufacturer’s instructions was also used as a source of purified
IgG (0.25 mg/mL) for bactericidal assays. Survival due to
alternative pathway mediated killing alone was determined by
comparing survival in BRS alone (no H. influenzae antibodies) and
by chelating NHS with gelatin veronal buffer containing
MgEGTA (Boston Bioproducts, Worcester, MA) [81]. Serum
pre-absorption of anti-LPS antibodies was conducted by incuba-
tion of NHS (1:50 dilution) with 1 mg LPS overnight at 4uC. Baby
rabbit serum was used as a source of complement without
antibody at a 1:20 dilution for H233, a 1:10 dilution for H729, and
a 1:25 dilution for Rd. Bactericidal assays with baby rabbit serum
were supplemented with IgG purified from NHS (4.8 mg) for
H233, or mAb 6E4 at a 1:10 dilution for H729 and a 1:100
dilution for Rd. Percent survival was determined relative to
complement-inactivated serum, which was incubated for 30 min
at 56uC prior to use. Assays to determine EDTA sensitivity were
performed by addition of EDTA (1–4 mM) to bacterial cells in
sBHI diluted in Hank’s buffer with Ca
2+ and Mg
2+, followed by
incubation for four hours at 37uC. Percent survival was
determined relative to no-EDTA controls.
LPS extraction
LPS extractions were performed using the phenol-chloroform-
petroleum ether method as previously described [82], with
modifications [83]. Briefly, bacterial pellets were washed sequen-
tially in ethanol, acetone, and petroleum ether prior to
lyophilization. The lyophilized samples were re-suspended and
mixed overnight in a 2:5:8 extraction mixture of phenol:
chloroform: petroleum ether. Following filtration and evaporation
of chloroform and petroleum ether, LPS was precipitated from
phenol in 5:1 mixture of acetone: diethyl ether. Ultracentrifuga-
tion was used to further purify LPS re-suspended in water,
followed by lyophilization.
Trypsin digestion and Cy5 detection of surface proteins
Partial digestion of outer membrane proteins with trypsin was
performed as previously described [84]. Briefly, 200 ml of mid-
logarithmic phase bacterial cells (OD620 0.5) were washed and re-
suspended in 10 mM Tris-HCL, pH 7.5. Following addition of
1 mg/mL trypsin, bacteria were incubated for 2 hrs at 37uC. The
cells were then washed and re-suspended in 10 mM carbonate
buffer prior to staining with Cy5 according to manufacturer’s
instructions (GE Biosciences Amersham, Buckinghamshire, UK).
Table 1. List of strains used in this study.
Strain Description Reference
H233 NTHi chronic bronchitis clinical isolate A860516 [87]
H632 NTHi otitis media clinical isolate SR7332.P1, Sm
a [88]
H707 NTHi COPD
b (non-exacerbation) clinical isolate [66]
H708 NTHi COPD (non-exacerbation) clinical isolate [66]
H725 NTHi COPD (exacerbation) clinical isolate [66]
H729 NTHi COPD (exacerbation) clinical isolate [66]
Rd Type d, unencapsulated isolate [89]
H446 Rd with lic1D::Km
c, constitutive ChoP2 [45]
H457 (H3)
d Rd with lic1D (Eagan) [45]
H491 (H1)
e Rd with lic1AD(CAAT)n, constitutive ChoP+ [45]
lpsA Rd lpsA::Km [90]
lpt6 Rd lpt6::Km [91]
opsX Rd opsX::Km [90]
orfH Rd orfH::Km [90]
Eagan Type b clinical isolate [92]
H625 Eagan, unencapsulated isolate
f [93]
H445 Eagan with lic1D:Km, constitutive ChoP2 [45]
aSm, spontaneous streptomycin resistant mutant,
bCOPD, chronic obstructive pulmonary disease,
cKm, contains kanamycin resistance cassette,
dH3, ChoP attached to hexose extension from HeptoseIII,
eH1, ChoP in natural position (for Rd) attached to hexose extension from
HeptoseI,
ftype b- spontaneous mutant lacking both copies of the cap locus.
doi:10.1371/journal.ppat.1002521.t001
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Cy5 (40 pmol) in the dark for 20 min, and reactions were stopped
with 20 ml of 10 mM lysine. Cells were washed with 10 mM
carbonate buffer and re-suspended in PBS with 1% bovine serum
albumin prior to flow cytometric analysis on a BD FACS Calibur
flow cytometer (BD Biosciences). A total of 50,000 cells were
collected from each reaction mixture, and the MFI of antibody
binding was determined using FlowJo software (Tree Star).
EtBr uptake assay
Ethidium bromide was used as a measure of outer membrane
permeability as previously described [46]. Bacterial cells grown to
stationary phase (OD620 0.8) were re-suspended in PBS, with
15 mg/mL polymyxin B and 6 mM EtBr added directly prior to
each measurement. Fluorescence was measured at an excitation
wavelength of 544 nm, an emission wavelength of 610 nm using
FLUOstar OPTIMA (BMG Labtech, Ortenberg, Germany). EtBr
uptake was expressed by RFU/s.
DSC analysis of LPS phase transition temperature
Purified LPS samples for each strain were diluted to 2 mg/mL
in PBS, sonicated, and subjected to three cycles of incubation at
56uC for five min, vortexing 1 min, and cooling to 4uC. Where
specified, MgCl2 was added to the PBS at 1:1 and 5:1 [MgCl2]:
[LPS] molar ratios. Following preparation, samples were stored at
4uC for several hours before running on the DSC instrument.
Heat capacity profiles were determined at a scan rate of 60uC/hr
over a temperature range of 10–60uC in a high-resolution
differential scanning calorimeter (MCS, MicroCal, Amherst,
MA). Three consecutive heating and cooling scans were measured
per sample. PBS buffer-buffer references were subtracted from
sample data, and concentration was normalized based on sample
concentration. The Microcal ORIGIN software package was used
to progress baselines. The gel-to-liquid crystalline phase transition
temperature, Tm, was determined by integration from baseline to
calculate the midpoint of the transition.
MS analysis
Purified LPS samples were subjected to mild acid hydrolysis and
electrospray ionization-mass spectrometry (ESI-MS) was per-
formed as previously described [85].
Statistical analysis
Differences between groups were assessed for statistical
significance using an unpaired Student’s t-test (GraphPad
PRISM4, GraphPad Software, La Jolla, CA).
Gene reference numbers
The reference numbers for genes mentioned in the text include:
opsX (0261), lpsA (0765), orfH (0523) and lpt6 (0258, 0259) from the
Rd database for the published genome sequence [86], as well as
lic1A (950399) and lic1D (950403) GeneID from the NCBI
GenBank database.
Acknowledgments
We would like to thank Derek W. Hood (University of Oxford) for
providing the LPS structural mutants, and M. Shchepetov for guidance
with LPS extractions. Also, we thank Michael A. Apicella (University of
Iowa) for kindly providing the mAb 6E4.
Author Contributions
Conceived and designed the experiments: SEC JS TAZ JNW. Performed
the experiments: SEC JL. Analyzed the data: SEC JS JL JNW. Contributed
reagents/materials/analysis tools: JNW. Wrote the paper: SEC JNW.
References
1. Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A, et al. (2009)
Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect
Dis J 28: 43–48.
2. Barkai G, Leibovitz E, Givon-Lavi N, Dagan R (2009) Potential contribution by
nontypable Haemophilus influenzae in protracted and recurrent acute otitis
media. Pediatr Infect Dis J 28: 466–471.
3. Murphy TF, Brauer AL, Schiffmacher AT, Sethi S (2004) Persistent colonization
by Haemophilus influenzae in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 170: 266–272.
4. Murphy TF, Sethi S, Klingman KL, Brueggemann AB, Doern GV (1999)
Simultaneous respiratory tract colonization by multiple strains of nontypeable
haemophilus influenzae in chronic obstructive pulmonary disease: implications
for antibiotic therapy. J Infect Dis 180: 404–409.
5. De Schutter I, De Wachter E, Crokaert F, Verhaegen J, Soetens O, et al. (2011)
Microbiology of Bronchoalveolar Lavage Fluid in Children With Acute
Nonresponding or Recurrent Community-Acquired Pneumonia: Identification
of Nontypeable Haemophilus influenzae as a Major Pathogen. Clin Infect Dis
52: 1437–1444.
6. Harabuchi Y, Faden H, Yamanaka N, Duffy L, Wolf J, et al. (1994)
Nasopharyngeal colonization with nontypeable Haemophilus influenzae and
recurrent otitis media. Tonawanda/Williamsville Pediatrics. J Infect Dis 170:
862–866.
7. Faden H, Duffy L, Wasielewski R, Wolf J, Krystofik D, et al. (1997) Relationship
between nasopharyngeal colonization and the development of otitis media in
children. Tonawanda/Williamsville Pediatrics. J Infect Dis 175: 1440–1445.
8. Gessner BD, Adegbola RA (2008) The impact of vaccines on pneumonia: key
lessons from Haemophilus influenzae type b conjugate vaccines. Vaccine 26
Suppl 2: B3–8.
9. Kalies H, Siedler A, Grondahl B, Grote V, Milde-Busch A, et al. (2009) Invasive
Haemophilus influenzae infections in Germany: impact of non-type b serotypes
in the post-vaccine era. BMC Infect Dis 9: 45.
10. Barenkamp SJ, Munson RS, Jr., Granoff DM (1981) Subtyping isolates of
Haemophilus influenzae type b by outer-membrane protein profiles. J Infect Dis
143: 668–676.
11. Gilsdorf JR (1998) Antigenic diversity and gene polymorphisms in Haemophilus
influenzae. Infect Immun 66: 5053–5059.
12. John CM, Liu M, Jarvis GA (2009) Profiles of structural heterogeneity in native
lipooligosaccharides of Neisseria and cytokine induction. J Lipid Res 50:
424–438.
13. Peng D, Hu WG, Choudhury BP, Muszynski A, Carlson RW, et al. (2007) Role
of different moieties from the lipooligosaccharide molecule in biological activities
of the Moraxella catarrhalis outer membrane. Febs J 274: 5350–5359.
14. Schweda EK, Richards JC, Hood DW, Moxon ER (2007) Expression and
structural diversity of the lipopolysaccharide of Haemophilus influenzae:
implication in virulence. Int J Med Microbiol 297: 297–306.
15. Engskog MK, Deadman M, Li J, Hood DW, Schweda EK (2011) Detailed
structural features of lipopolysaccharide glycoforms in nontypeable Haemoph-
ilus influenzae strain 2019. Carbohydr Res 346: 1241–1249.
16. Lundstrom SL, Twelkmeyer B, Sagemark MK, Li J, Richards JC, et al. (2007)
Novel globoside-like oligosaccharide expression patterns in nontypeable
Haemophilus influenzae lipopolysaccharide. Febs J 274: 4886–4903.
17. Lundstrom SL, Li J, Deadman ME, Hood DW, Moxon ER, et al. (2008)
Structural analysis of the lipopolysaccharide from nontypeable Haemophilus
influenzae strain R2846. Biochemistry 47: 6025–6038.
18. Mansson M, Bauer SH, Hood DW, Richards JC, Moxon ER, et al. (2001) A
new structural type for Haemophilus influenzae lipopolysaccharide. Structural
analysis of the lipopolysaccharide from nontypeable Haemophilus influenzae
strain 486. Eur J Biochem 268: 2148–2159.
19. Mansson M, Hood DW, Moxon ER, Schweda EK (2003) Structural
characterization of a novel branching pattern in the lipopolysaccharide from
nontypeable Haemophilus influenzae. Eur J Biochem 270: 2979–2991.
20. Risberg A, Masoud H, Martin A, Richards JC, Moxon ER, et al. (1999)
Structural analysis of the lipopolysaccharide oligosaccharide epitopes expressed
by a capsule-deficient strain of Haemophilus influenzae Rd. Eur J Biochem 261:
171–180.
21. Masoud H, Moxon ER, Martin A, Krajcarski D, Richards JC (1997) Structure
of the variable and conserved lipopolysaccharide oligosaccharide epitopes
expressed by Haemophilus influenzae serotype b strain Eagan. Biochemistry 36:
2091–2103.
22. Swords WE, Jones PA, Apicella MA (2003) The lipo-oligosaccharides of
Haemophilus influenzae: an interesting array of characters. J Endotoxin Res 9:
131–144.
Phosphorylcholine Allows Evasion of Antibody
PLoS Pathogens | www.plospathogens.org 12 March 2012 | Volume 8 | Issue 3 | e100252123. Power PM, Sweetman WA, Gallacher NJ, Woodhall MR, Kumar GA, et al.
(2009) Simple sequence repeats in Haemophilus influenzae. Infect Genet Evol 9:
216–228.
24. Kolberg J, Hoiby EA, Jantzen E (1997) Detection of the phosphorylcholine
epitope in streptococci, Haemophilus and pathogenic Neisseriae by immuno-
blotting. Microb Pathog 22: 321–329.
25. Weiser JN, Goldberg JB, Pan N, Wilson L, Virji M (1998) The phosphoryl-
choline epitope undergoes phase variation on a 43-kilodalton protein in
Pseudomonas aeruginosa and on pili of Neisseria meningitidis and Neisseria
gonorrhoeae. Infect Immun 66: 4263–4267.
26. Gillespie SH, Ainscough S, Dickens A, Lewin J (1996) Phosphorylcholine-
containing antigens in bacteria from the mouth and respiratory tract. J Med
Microbiol 44: 35–40.
27. Cabot MC, Welsh CJ, Cao HT, Chabbott H (1988) The phosphatidylcholine
pathway of diacylglycerol formation stimulated by phorbol diesters occurs via
phospholipase D activation. FEBS Lett 233: 153–157.
28. Fan X, Pericone CD, Lysenko E, Goldfine H, Weiser JN (2003) Multiple
mechanisms for choline transport and utilization in Haemophilus influenzae.
Mol Microbiol 50: 537–548.
29. Weiser JN, Maskell DJ, Butler PD, Lindberg AA, Moxon ER (1990)
Characterization of repetitive sequences controlling phase variation of
Haemophilus influenzae lipopolysaccharide. J Bacteriol 172: 3304–3309.
30. De Bolle X, Bayliss CD, Field D, van de Ven T, Saunders NJ, et al. (2000) The
length of a tetranucleotide repeat tract in Haemophilus influenzae determines
the phase variation rate of a gene with homology to type III DNA
methyltransferases. Mol Microbiol 35: 211–222.
31. Weiser JN, Pan N, McGowan KL, Musher D, Martin A, et al. (1998)
Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae
contributes to persistence in the respiratory tract and sensitivity to serum killing
mediated by C-reactive protein. J Exp Med 187: 631–640.
32. Humphries HE, High NJ (2002) The role of licA phase variation in the
pathogenesis of invasive disease by Haemophilus influenzae type b. FEMS
Immunol Med Microbiol 34: 221–230.
33. Briles DE, Forman C, Crain M (1992) Mouse antibody to phosphocholine can
protect mice from infection with mouse-virulent human isolates of Streptococcus
pneumoniae. Infect Immun 60: 1957–1962.
34. Tanaka N, Fukuyama S, Fukuiwa T, Kawabata M, Sagara Y, et al. (2007)
Intranasal immunization with phosphorylcholine induces antigen specific
mucosal and systemic immune responses in mice. Vaccine 25: 2680–2687.
35. Tong HH, Blue LE, James MA, Chen YP, DeMaria TF (2000) Evaluation of
phase variation of nontypeable Haemophilus influenzae lipooligosaccharide
during nasopharyngeal colonization and development of otitis media in the
chinchilla model. Infect Immun 68: 4593–4597.
36. Pang B, Winn D, Johnson R, Hong W, West-Barnette S, et al. (2008)
Lipooligosaccharides containing phosphorylcholine delay pulmonary clearance
of nontypeable Haemophilus influenzae. Infect Immun 76: 2037–2043.
37. Marti-Lliteras P, Lopez-Gomez A, Mauro S, Hood DW, Viadas C, et al. (2011)
Nontypable Haemophilus influenzae Displays a Prevalent Surface Structure
Molecular Pattern in Clinical Isolates. PLoS One 6: e21133.
38. Swords WE, Buscher BA, Ver Steeg Ii K, Preston A, Nichols WA, et al. (2000)
Non-typeable Haemophilus influenzae adhere to and invade human bronchial
epithelial cells via an interaction of lipooligosaccharide with the PAF receptor.
Mol Microbiol 37: 13–27.
39. Branger J, Wieland CW, Florquin S, Maris NA, Pater JM, et al. (2004) Platelet-
activating factor receptor-deficient mice show an unaltered clearance of
nontypeable Haemophilus influenzae from their respiratory tract. Shock 22:
543–547.
40. Zola TA, Lysenko ES, Weiser JN (2009) Natural antibody to conserved targets of
Haemophilus influenzae limits colonization of the murine nasopharynx. Infect
Immun 77: 3458–3465.
41. Bosma MJ, Carroll AM (1991) The SCID mouse mutant: definition,
characterization, and potential uses. Annu Rev Immunol 9: 323–350.
42. Spinola SM, Kwaik YA, Lesse AJ, Campagnari AA, Apicella MA (1990) Cloning
and expression in Escherichia coli of a Haemophilus influenzae type b
lipooligosaccharide synthesis gene(s) that encodes a 2-keto-3-deoxyoctulosonic
acid epitope. Infect Immun 58: 1558–1564.
43. Risberg A, Alvelius G, Schweda EK (1999) Structural analysis of the
lipopolysaccharide oligosaccharide epitopes expressed by Haemophilus influen-
zae strain RM.118-26. Eur J Biochem 265: 1067–1074.
44. Risberg A, Schweda EK, Jansson PE (1997) Structural studies of the cell-
envelope oligosaccharide from the lipopolysaccharide of Haemophilus influen-
zae strain RM.118-28. Eur J Biochem 243: 701–707.
45. Lysenko E, Richards JC, Cox AD, Stewart A, Martin A, et al. (2000) The
position of phosphorylcholine on the lipopolysaccharide of Haemophilus
influenzae affects binding and sensitivity to C-reactive protein-mediated killing.
Mol Microbiol 35: 234–245.
46. Murata T, Tseng W, Guina T, Miller SI, Nikaido H (2007) PhoPQ-mediated
regulation produces a more robust permeability barrier in the outer membrane
of Salmonella enterica serovar typhimurium. J Bacteriol 189: 7213–7222.
47. Noordam PC, van Echteld CJ, de Kruijff B, Verkleij AJ, de Gier J (1980) Barrier
characteristics of membrane model systems containing unsaturated phosphati-
dylethanolamines. Chem Phys Lipids 27: 221–232.
48. Coughlin RT, Haug A, McGroarty EJ (1983) Physical properties of defined
lipopolysaccharide salts. Biochemistry 22: 2007–2013.
49. Snyder S, Kim D, McIntosh TJ (1999) Lipopolysaccharide bilayer structure:
effect of chemotype, core mutations, divalent cations, and temperature.
Biochemistry 38: 10758–10767.
50. Nikaido H (2003) Molecular basis of bacterial outer membrane permeability
revisited. Microbiol Mol Biol Rev 67: 593–656.
51. Garidel P, Rappolt M, Schromm AB, Howe J, Lohner K, et al. (2005) Divalent
cations affect chain mobility and aggregate structure of lipopolysaccharide from
Salmonella minnesota reflected in a decrease of its biological activity. Biochim
Biophys Acta 1715: 122–131.
52. Samuelson A, Borrelli S, Gustafson R, Hammarstrom L, Smith CI, et al. (1995)
Characterization of Haemophilus influenzae isolates from the respiratory tract of
patients with primary antibody deficiencies: evidence for persistent colonizations.
Scand J Infect Dis 27: 303–313.
53. Rojas R, Apodaca G (2002) Immunoglobulin transport across polarized
epithelial cells. Nat Rev Mol Cell Biol 3: 944–955.
54. Nurkka A, Ahman H, Korkeila M, Jantti V, Kayhty H, et al. (2001) Serum and
salivary anti-capsular antibodies in infants and children immunized with the
heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J 20: 25–33.
55. Mukundan D, Ecevit Z, Patel M, Marrs CF, Gilsdorf JR (2007) Pharyngeal
colonization dynamics of Haemophilus influenzae and Haemophilus haemoly-
ticus in healthy adult carriers. J Clin Microbiol 45: 3207–3217.
56. Moxon R, Bayliss C, Hood D (2006) Bacterial contingency loci: the role of
simple sequence DNA repeats in bacterial adaptation. Annu Rev Genet 40:
307–333.
57. Fox KL, Yildirim HH, Deadman ME, Schweda EK, Moxon ER, et al. (2005)
Novel lipopolysaccharide biosynthetic genes containing tetranucleotide repeats
in Haemophilus influenzae, identification of a gene for adding O-acetyl groups.
Mol Microbiol 58: 207–216.
58. Hood DW, Makepeace K, Deadman ME, Rest RF, Thibault P, et al. (1999)
Sialic acid in the lipopolysaccharide of Haemophilus influenzae: strain
distribution, influence on serum resistance and structural characterization.
Mol Microbiol 33: 679–692.
59. Erwin AL, Allen S, Ho DK, Bonthuis PJ, Jarisch J, et al. (2006) Role of lgtC in
resistance of nontypeable Haemophilus influenzae strain R2866 to human
serum. Infect Immun 74: 6226–6235.
60. Campagnari AA, Gupta MR, Dudas KC, Murphy TF, Apicella MA (1987)
Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influen-
zae. Infect Immun 55: 882–887.
61. Barbier M, Oliver A, Rao J, Hanna SL, Goldberg JB, et al. (2008) Novel
phosphorylcholine-containing protein of Pseudomonas aeruginosa chronic
infection isolates interacts with airway epithelial cells. J Infect Dis 197: 465–473.
62. Warren MJ, Jennings MP (2003) Identification and characterization of pptA: a
gene involved in the phase-variable expression of phosphorylcholine on pili of
Neisseria meningitidis. Infect Immun 71: 6892–6898.
63. Fischer W (2000) Phosphocholine of pneumococcal teichoic acids: role in
bacterial physiology and pneumococcal infection. Res Microbiol 151: 421–427.
64. Mukherjee S, Liu X, Arasaki K, McDonough J, Galan JE, et al. (2011)
Modulation of Rab GTPase function by a protein phosphocholine transferase.
Nature 477: 103–106.
65. Fox KL, Li J, Schweda EK, Vitiazeva V, Makepeace K, et al. (2008) Duplicate
copies of lic1 direct the addition of multiple phosphocholine residues in the
lipopolysaccharide of Haemophilus influenzae. Infect Immun 76: 588–600.
66. Nakamura S, Shchepetov M, Dalia AB, Clark SE, Murphy TF, et al. (2011)
Molecular Basis of Increased Serum Resistance among Pulmonary Isolates of
Non-typeable Haemophilus influenzae. PLoS Pathog 7: e1001247.
67. Zhang L, Dhillon P, Yan H, Farmer S, Hancock RE (2000) Interactions of
bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of
Pseudomonas aeruginosa. Antimicrob Agents Chemother 44: 3317–3321.
68. Lysenko ES, Gould J, Bals R, Wilson JM, Weiser JN (2000) Bacterial
phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/
hCAP18 expressed in the upper respiratory tract. Infect Immun 68: 1664–1671.
69. Bengoechea JA, Brandenburg K, Arraiza MD, Seydel U, Skurnik M, et al.
(2003) Pathogenic Yersinia enterocolitica strains increase the outer membrane
permeability in response to environmental stimuli by modulating lipopolysac-
charide fluidity and lipid A structure. Infect Immun 71: 2014–2021.
70. Viau C, Le Sage V, Ting DK, Gross J, Le Moual H (2011) Absence of PmrAB-
mediated phosphoethanolamine modifications of Citrobacter rodentium lipo-
polysaccharide affects outer membrane integrity. J Bacteriol 193: 2168–2176.
71. Brandenburg K, Seydel U (1990) Investigation into the fluidity of lipopolysac-
charide and free lipid A membrane systems by Fourier-transform infrared
spectroscopy and differential scanning calorimetry. Eur J Biochem 191:
229–236.
72. Huang C, Wang ZQ, Lin HN, Brumbaugh EE, Li S (1994) Interconversion of
bilayer phase transition temperatures between phosphatidylethanolamines and
phosphatidylcholines. Biochim Biophys Acta 1189: 7–12.
73. Brandenburg K, Blume A (1987) Investigations into the thermotropic phase
behaviour of natural membranes extracted from gram-negative bacteria and
artificial membrane systems made from lipopolysaccharides and free lipid A.
Thermochimica Act 119: 127–142.
74. Amro NA, Kotra LP, Wadu-Mesthrige K, Bulychev A, Mobashery S, et al.
(2000) High-resolution atomic force microscopy studies of the Escherichia coli
outer membrane: structural basis for permeability. Langmuir 16: 2789–2796.
75. Vaara M (1992) Agents that increase the permeability of the outer membrane.
Microbiol Rev 56: 395–411.
Phosphorylcholine Allows Evasion of Antibody
PLoS Pathogens | www.plospathogens.org 13 March 2012 | Volume 8 | Issue 3 | e100252176. Lee H, Hsu FF, Turk J, Groisman EA (2004) The PmrA-regulated pmrC gene
mediates phosphoethanolamine modification of lipid A and polymyxin resistance
in Salmonella enterica. J Bacteriol 186: 4124–4133.
77. Reynolds CM, Kalb SR, Cotter RJ, Raetz CR (2005) A phosphoethanolamine
transferase specific for the outer 3-deoxy-D-manno-octulosonic acid residue of
Escherichia coli lipopolysaccharide. Identification of the eptB gene and Ca2+
hypersensitivity of an eptB deletion mutant. J Biol Chem 280: 21202–21211.
78. Michalka J, Goodgal SH (1969) Genetic and physical map of the chromosome of
Hemophilus influenzae. J Mol Biol 45: 407–421.
79. Weiser JN, Shchepetov M, Chong ST (1997) Decoration of lipopolysaccharide
with phosphorylcholine: a phase-variable characteristic of Haemophilus
influenzae. Infect Immun 65: 943–950.
80. Virji M, Weiser JN, Lindberg AA, Moxon ER (1990) Antigenic similarities in
lipopolysaccharides of Haemophilus and Neisseria and expression of a
digalactoside structure also present on human cells. Microb Pathog 9: 441–450.
81. Gillin FD, Sher A (1981) Activation of the alternative complement pathway by
Trichomonas vaginalis. Infect Immun 34: 268–273.
82. Galanos C, Luderitz O, Westphal O (1969) A new method for the extraction of
R lipopolysaccharides. Eur J Biochem 9: 245–249.
83. Schweda EK, Richards JC (2010) Profiling LPS glycoforms of non-typeable
Haemophilus influenzae by multiple-stage tandem mass spectrometry. Methods
Mol Biol 600: 79–92.
84. Morton DJ, Williams P (1989) Characterization of the outer-membrane proteins
of Haemophilus parainfluenzae expressed under iron-sufficient and iron-
restricted conditions. J Gen Microbiol 135: 445–451.
85. Lundstrom SL, Li J, Mansson M, Figueira M, Leroy M, et al. (2008) Application
of capillary electrophoresis mass spectrometry and liquid chromatography
multiple-step tandem electrospray mass spectrometry to profile glycoform
expression during Haemophilus influenzae pathogenesis in the chinchilla model
of experimental otitis media. Infect Immun 76: 3255–3267.
86. Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, et al. (1995)
Whole-genome random sequencing and assembly of Haemophilus influenzae
Rd. Science 269: 496–512.
87. van Alphen L, Caugant DA, Duim B, O’Rourke M, Bowler LD (1997)
Differences in genetic diversity of nonecapsulated Haemophilus influenzae from
various diseases. Microbiology 143(Pt 4): 1423–1431.
88. Mason KW, Zhu D, Scheuer CA, McMichael JC, Zlotnick GW, et al. (2004)
Reduction of nasal colonization of nontypeable Haemophilus influenzae
following intranasal immunization with rLP4/rLP6/UspA2 proteins combined
with aqueous formulation of RC529. Vaccine 22: 3449–3456.
89. Alexander HE, Leidy G (1953) Induction of streptomycin resistance in sensitive
Hemophilus influenzae by extracts containing desoxyribonucleic acid from
resistant Hemophilus influenzae. J Exp Med 97: 17–31.
90. Hood DW, Deadman ME, Allen T, Masoud H, Martin A, et al. (1996) Use of
the complete genome sequence information of Haemophilus influenzae strain
Rd to investigate lipopolysaccharide biosynthesis. Mol Microbiol 22: 951–965.
91. Wright JC, Hood DW, Randle GA, Makepeace K, Cox AD, et al. (2004) lpt6, a
gene required for addition of phosphoethanolamine to inner-core lipopolysac-
charide of Neisseria meningitidis and Haemophilus influenzae. J Bacteriol 186:
6970–6982.
92. Weiser JN, Love JM, Moxon ER (1989) The molecular mechanism of phase
variation of H. influenzae lipopolysaccharide. Cell 59: 657–665.
93. Hoiseth SK, Connelly CJ, Moxon ER (1985) Genetics of spontaneous, high-
frequency loss of b capsule expression in Haemophilus influenzae. Infect Immun
49: 389–395.
Phosphorylcholine Allows Evasion of Antibody
PLoS Pathogens | www.plospathogens.org 14 March 2012 | Volume 8 | Issue 3 | e1002521